Alpha-9 Oncology
Vancouver, CA · 39 employees on LinkedIn · 16 known investors
Find your way into Alpha-9 Oncology
Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development. The company serves patients with cancer through novel drug candidates advancing in clinical trials.
Founders & leadership
FB
François BénardMD
KL
Kuo-Shyan LinPhD
DP
David PerrinPhD
Investors · 16
Andreessen HorowitzMenlo Park · $500K – $50M
Delos CapitalCambridge
.png)
General CatalystSan Francisco · $30M
Lightspeed Venture PartnersMenlo Park · $1.7M – $87M
Longitude CapitalMenlo Park · $10M – $30M
Lumira VenturesToronto · $1M – $10M
Nextech InvestZurich · $648K – $3.2M
RA CapitalBoston
Samsara BioCapitalPalo Alto
abrdn plcreportedEdinburgh
Ascenta CapitalreportedWilmington
Biotechnology Value FundreportedSan Francisco
Digitalis Venturesreported · 2 sourcesNew York · $100K – $10M
Frazier Life SciencesreportedPalo Alto
Janus Henderson InvestorsreportedLondon
Also in the syndicate · 1
a16z Bio + Health
Funding
SEC filings, press & company announcements$175M disclosed across 1 round · 2024
- $175Mseries COct 2024 · 3 sources
Ascenta Capital (lead), Lightspeed Venture Partners (lead), a16z Bio + Health, abrdn plc, Biotechnology Value Fund, Frazier Life Sciences, Janus Henderson Investors, RA Capital Management, Samsara BioCapital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapBioworld14 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Itnonline12 shared keywordsImaging Technology News is a trade publication that reaches over 34,000 radiology, radiation oncology, women's health, and nuclear medicine professionals with editorial content and product comparison tools. The publication serves as a primary resource for healthcare technology purchasing decisions within medical imaging specialties.
Companies competing with Alpha-9 Oncology for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Alpha-9 Oncology do?
- Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development. The company serves patients with cancer through novel drug candidates advancing in clinical trials.
- Who founded Alpha-9 Oncology?
- Alpha-9 Oncology was founded by François Bénard, Kuo-Shyan Lin, David Perrin.
- Who are Alpha-9 Oncology's investors?
- Alpha-9 Oncology's investors include Andreessen Horowitz, Delos Capital, General Catalyst, Lightspeed Venture Partners, Longitude Capital, Lumira Ventures, Nextech Invest, RA Capital and 7 more.
- How much funding has Alpha-9 Oncology raised?
- Alpha-9 Oncology has disclosed $175M raised across 1 round.
- Where is Alpha-9 Oncology headquartered?
- Alpha-9 Oncology is headquartered in Vancouver, CA.